Thompson Siegel & Walmsley LLC Johnson & Johnson Transaction History

Thompson Siegel & Walmsley LLC

$6.71 Billion
Q3 2024

A detailed history of Thompson Siegel & Walmsley LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 102,529 shares of JNJ stock, worth $15.9 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

102,529

Previous 117,735 12.92%

Holding current value

$15.9 Million

Previous $17.2 Million 3.44%

% of portfolio

0.25%

Previous 0.28%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$145.48 - $167.38 $2.21 Million - $2.55 Million	-15,206 Reduced 12.92%	102,529 $16.6 Million
Q2 2024 Aug 08, 2024	SELL	$144.38 - $157.78 $130,086 - $142,159	-901 Reduced 0.76%	117,735 $17.2 Million
Q1 2024 May 09, 2024	SELL	$155.22 - $162.74 $111,758 - $117,172	-720 Reduced 0.6%	118,636 $18.8 Million
Q4 2023 Feb 07, 2024	SELL	$145.6 - $158.88 $162,052 - $176,833	-1,113 Reduced 0.92%	119,356 $18.7 Million
Q3 2023 Nov 08, 2023	BUY	$155.75 - $174.48 $3,893 - $4,362	25 Added 0.02%	120,469 $18.8 Million
Q2 2023 Aug 10, 2023	SELL	$154.35 - $166.11 $109,897 - $118,270	-712 Reduced 0.59%	120,444 $19.9 Million
Q1 2023 May 11, 2023	BUY	$151.05 - $180.26 $2.07 Million - $2.47 Million	13,683 Added 12.73%	121,156 $18.8 Million
Q4 2022 Feb 10, 2023	BUY	$160.2 - $179.79 $17.2 Million - $19.3 Million	107,473 New	107,473 $19 Million
Q3 2022 Oct 25, 2022	SELL	$161.33 - $179.52 $382,674 - $425,821	-2,372 Reduced 2.14%	108,416 $17.7 Million
Q2 2022 Jul 22, 2022	BUY	$168.19 - $186.01 $549,308 - $607,508	3,266 Added 3.04%	110,788 $19.7 Million
Q1 2022 Apr 26, 2022	BUY	$158.14 - $179.59 $1.11 Million - $1.26 Million	7,006 Added 6.97%	107,522 $19.1 Million
Q4 2021 Feb 09, 2022	BUY	$155.93 - $173.01 $1.89 Million - $2.09 Million	12,109 Added 13.7%	100,516 $17.2 Million
Q3 2021 Nov 05, 2021	BUY	$161.5 - $179.47 $714,476 - $793,975	4,424 Added 5.27%	88,407 $14.3 Million
Q2 2021 Aug 09, 2021	BUY	$159.48 - $171.07 $488,008 - $523,474	3,060 Added 3.78%	83,983 $13.8 Million
Q1 2021 May 07, 2021	SELL	$153.07 - $170.48 $346,397 - $385,796	-2,263 Reduced 2.72%	80,923 $13.3 Million
Q4 2020 Feb 08, 2021	SELL	$137.11 - $157.38 $405,022 - $464,900	-2,954 Reduced 3.43%	83,186 $13.1 Million
Q3 2020 Nov 12, 2020	BUY	$140.38 - $153.83 $778,547 - $853,141	5,546 Added 6.88%	86,140 $12.8 Million
Q2 2020 Aug 11, 2020	SELL	$128.81 - $155.51 $591,881 - $714,568	-4,595 Reduced 5.39%	80,594 $11.3 Million
Q1 2020 May 12, 2020	SELL	$111.14 - $153.99 $894,454 - $1.24 Million	-8,048 Reduced 8.63%	85,189 $11.2 Million
Q4 2019 Feb 07, 2020	BUY	$127.5 - $146.44 $72,165 - $82,885	566 Added 0.61%	93,237 $13.6 Million
Q3 2019 Nov 12, 2019	SELL	$126.95 - $142.14 $230,795 - $258,410	-1,818 Reduced 1.92%	92,671 $12 Million
Q2 2019 Aug 12, 2019	SELL	$131.15 - $144.24 $64,919 - $71,398	-495 Reduced 0.52%	94,489 $13.2 Million
Q1 2019 May 13, 2019	SELL	$125.72 - $139.79 $181,036 - $201,297	-1,440 Reduced 1.49%	94,984 $13.3 Million
Q4 2018 Feb 11, 2019	SELL	$122.84 - $147.84 $135,124 - $162,624	-1,100 Reduced 1.13%	96,424 $12.4 Million
Q3 2018 Nov 08, 2018	SELL	$121.58 - $142.88 $78,540 - $92,300	-646 Reduced 0.66%	97,524 $13.5 Million
Q2 2018 Aug 09, 2018	BUY	$119.4 - $131.76 $298,858 - $329,795	2,503 Added 2.62%	98,170 $11.9 Million
Q1 2018 May 08, 2018	SELL	$125.1 - $148.14 $124,599 - $147,547	-996 Reduced 1.03%	95,667 $12.3 Million
Q4 2017 Feb 09, 2018	BUY	$131.22 - $143.62 $349,307 - $382,316	2,662 Added 2.83%	96,663 $13.5 Million
Q3 2017 Nov 08, 2017	BUY	$129.47 - $135.38 $94,254 - $98,556	728 Added 0.78%	94,001 $12.2 Million
Q2 2017 Aug 09, 2017	BUY	N/A	93,273	93,273 $12.3 Million

Others Institutions Holding JNJ

# of Institutions

4,271

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.

Account

Thompson Siegel & Walmsley LLC Johnson & Johnson Transaction History